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Abstract: Sulphated polysaccharides (SP) extracted from seaweeds have antiviral properties 
and are much less cytotoxic than conventional drugs, but little is known about their mode  
of action. Combination antiviral chemotherapy may offer advantages over single agent 
therapy, increasing efficiency, potency and delaying the emergence of resistant virus. The 
paramyxoviridae family includes pathogens causing morbidity and mortality worldwide in 
humans and animals, such as the Newcastle Disease Virus (NDV) in poultry. This study  
aims at determining the antiviral activity and mechanism of action in vitro of an ulvan (SP 
from the green seaweed Ulva clathrata), and of its mixture with a fucoidan (SP from 
Cladosiphon okamuranus), against La Sota NDV strain. The ulvan antiviral activity was 
tested using syncytia formation, exhibiting an IC50 of 0.1 μg/mL; ulvan had a better anti  
cell-cell spread effect than that previously shown for fucoidan, and inhibited cell-cell fusion 
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via a direct effect on the F0 protein, but did not show any virucidal effect. The mixture of 
ulvan and fucoidan showed a greater anti-spread effect than SPs alone, but ulvan antagonizes 
the effect of fucoidan on the viral attachment/entry. Both SPs may be promising antivirals 
against paramyxovirus infection but their mixture has no clear synergistic advantage. 
Keywords: antiviral; seaweeds; sulphated polysaccharides; Ulva clathrata; Cladosiphon 
okamuranus; Newcastle Disease Virus 
 
1. Introduction 
Since the first report of the antiviral activity of sulphated polysaccharides in 1958 [1], a large number 
of SP have been found to possess a broad spectrum of antiviral activity. Nowadays a number of these 
SP have been demonstrated to be potent inhibitors of paramyxoviruses, including parainfluenza virus, 
respiratory syncytial virus, mumps virus, measles virus, NDV, and distemper canine virus [2–4]. Ulvales 
(chlorophyta) are seaweeds distributed worldwide. The genera Ulva, before Enteromorpha, is grown and 
collected for food consumption [5,6]. Among the polymers synthetized by these Ulva sp., cell wall 
polysaccharides represents 38%–54% of all dry algal matter [7], and can be classified in four polysaccharide 
families: two major ones, ulvan and cellulose and two minor ones, xyloglucan and glucurunan. Ulvan, 
the most important one, has been characterized with a variety of biological features [8–14]; among these, 
the immunomodulatory effect and the antiviral activity have focused the attention of scientists worldwide 
and marked a trend in drugs development. The main constituents reported in ulvans from several Ulvales 
species [15–19] are: Rhamnose (16.8%–45.0% dw), xylose (2.1%–12.0%), glucose (0.5%–6.4%), uronic 
acid (6.5%–19.0%), sulphate (16.0%–23.2%) and iduronic acid (1.1%–9.1%), rhamnose occurring mainly 
in the form of the aldobiouronic acid, 4-O-β-D-glucuronosyl-L-rhamnose. 
Newcastle disease virus (NDV) is the causative agent of one of the most serious threats to the poultry 
industry and causes enormous economic losses because of its worldwide distribution and high flock 
mortality [20]. It belongs to the Paramyxoviridae family, which groups enveloped, negative-sense 
single-stranded RNA viruses [21], and utilizes its genome to code for six proteins from the 3′ terminus 
to the 5′ terminus [22]. The viral lipid envelope contains the viral glycoproteins HN (attachment protein) 
and F (fusion protein), both being needed for efficient infection of cells; the F glycoprotein mediates the 
penetration of the cellular membrane during viral entry [22]. Currently there are no antiviral agents 
available against NDV in poultry, hence the importance of developing new alternative control measures. 
In our study, we evaluated the anti-NDV activity and mechanism of action of the SP ulvan (isolated 
from the green algae Ulva clathrata) and of a mixture with Cladosiphon okamuranus fucoidan, which 
mode of action has previously been characterized [3,4], for the purpose of developing new candidates 
anti- paramyxovirus drugs. 
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2. Results and Discussion 
2.1. Composition of Ulva Clathrata Powder and Ulvan Extract 
The composition of the starting Ulva clathrata powder was 22.4% ash, 15.3% protein, 9.5% sulphate, 
11.4% rhamnose, 7.3% glucuronic acid, 3.0% xylose, 2.5% glucose and 1.4% galactose. The final 
composition of the ulvan extract was 19% ash, 10.0% protein, 11.0% sulphate, 21.7% rhamnose,  
13.9% glucuronic acid, 6.1% glucose, 5.0% xylose, 3.6% iduronic acid, and 2.2% galactose. The molecular 
weight was 359,800 g·mol−1 equivalent pullulan. Ulva sp. powder is known to contain high amounts of 
good-quality protein, carbohydrate, vitamins and minerals [23]. Ulva clathrata chemical composition 
found in present study is on the line with that reported by Peña-Rodriguez et al. [15] for the same  
Ulva species. Ulvan composition has been widely studied [7,19] and showed to vary according to several 
factors including the period of collection, the ecophysiological growth conditions, the taxonomic origins 
and the post-collection treatment of the algal sources [7]. Extraction is conventionally achieved by using 
warm water (80–90 °C) containing ammonium oxalate as a divalent cation chelator, and the recovery  
of ulvan is generally obtained by precipitation in ethanol. As ulvan precipitation with ethanol is not 
specific, the extraction and purification are not completely effective in the removal of cellulose, 
hemicellulose, proteins and ash [24]. The final step for removing contaminants may vary considerably. 
Ulvan is mainly built on disaccharides repeating sequences composed of sulphated rhamnose and 
glucuronic acid, iduronic acid or xylose. Low proportions of galactose, glucose and protein are also 
generally found in ulvan [7,19,25]. The sugar composition of the purified U. clathrata ulvan obtained in 
present study is very similar to that given by Quemener et al. [25] for an U. lactuca ulvan that contained 
rhamnose 20.8%, glucuronic acid 16.0%, iduronic acid 3.7%, xylose 3.5%, glucose 2.8%, and galactose 
0.7%; this Ulva lactuca ulvan also contained protein 11.6% and sulphate 21.2%. These values are 
congruent with those reported for ulvan from other origins [26–28]. The polysaccharide extracted  
from U. clathrata in present study was more sulphated than those reported for Ulva armoricana  
(10.3%–13.8%) and Ulva rotundata (9.2%–12.5%) [16,29] but similar to those obtained from  
Ulva conglobata (23.04%–35.2%) [14], and less sulphated than the Ulva clathrata ulvan reported by 
Hernandez-Garibay et al. [30]. Ulvan PS characterization was completed by FT-IR and H-NMR spectra: 
the FT-IR spectrum (Figure 1) is comparable with the previously published data for Ulva rigida and 
Ulva pertusa polysaccharides [28,31]. A characteristic band at 3341.03 cm-1 corresponding to -OH 
groups, which is consistent with the structure of disaccharides is observed. Two bands at 1226.83 cm−1 
and 789 cm−1 are indicatives to the bounds C-O-S of sulfated groups. The band 1623 cm−1 is allocated 
to the vibration of C=O of the uronic acid; H-NMR spectrum (Figure 2) is comparable with data for 
ulvans [32]. All aromatic protons bound to -OH groups are in the region of 4.5 to 5.0. Protons attached 
to ether groups are allocated in the region of 3.4 to 3.6. Methyl protons of rhamnose are assigned in the 
region of 0.8 to 1.1. 
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Figure 1. Infrared absorption spectrum of the native ulvan from Ulva clathrata. 
 
Figure 2. 1H-NMR spectrum in D2O of the native ulvan from Ulva clathrata. 
2.2. Cytotoxicity of the SP 
To determine the cytotoxicity of SP and their mixture, MTT assays were performed. No significant 
cytotoxicity was detected for the SP at concentrations up to 100 μg/mL in Vero cells; the 50% cytotoxic 
concentrations (CC50) for fucoidan, ulvan and the mixture were of 1336 μg/mL, 810 μg/mL and 823 μg/mL, 
respectively (Figure 3a, Table 1). This is consistent with studies that have assessed the cytotoxicity of 
other SP in cell culture, showing lower toxicity than commercial, FDA-approved, antiviral drugs [3,8,33]. 
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Figure 3. Cytotoxicity and antiviral activity of sulphated polysaccharides (SP) against 
Newcastle Disease Virus (NDV). (a) Vero cells (6.5 × 103 cells), seeded in 96-well plates, 
were treated with different concentrations of SP for 48 h. Cell viability was then determined 
in triplicates by the MTT assay and compared with that in untreated cells (100% viability); 
(b) Vero cells (6.7 × 104 cells), seeded in 24-well plates, were infected with NDV and treated 
with different concentrations of SP during infection for 1 h, and the antiviral activity was 
determined in a syncytia reduction assay. The data shown are the mean ± standard deviation 
(SD) of triplicate cultures, and the experiment was repeated three times. CC, cellular control; 
CV, viral control. 
Table 1. Antiviral activity and cytotoxicity of sulphated polysaccharides. 
Polysaccharide 
Vero Cell Line 
CC50 (μg/mL) a IC50 (μg/mL) b SI c 
Fucoidan 1136 0.01 113,633 
Ulvan 810 0.1 8102.5 
Fuc/Ulv 823 0.01 82,325 
a Concentration of test compound (μg/mL) that reduced Vero cell viability by 50%. b Concentration of a test 
compound that reduced the number of NDV syncytia in Vero cells by 50%. c Values of selectivity index. 
2.3. Antiviral Activity in Vitro 
The antiviral activity of the SP against NDV was evaluated by syncytia reduction assays. Vero cell 
monolayers were treated with different concentrations below or equal to 100 μg/mL of the ulvan, 
fucoidan and their mixture [1:1] at the time of infection with 1 × 105.5 TCID50 of NDV, and the concentration 
of the SP was maintained throughout the infection. As shown in Figure 3b, a concentration-dependent 
inhibition of viral entry into the host cells was observed with the addition of the SP compared to the 
findings in the untreated control cells. The results showed that the SP inhibits syncytia formation,  
with 50% inhibitory concentrations (IC50) values of 0.01 μg/mL, 0.1 μg/mL and 0.01 μg/mL for 
fucoidan, ulvan and the mixture, respectively. 
The selectivity index (SI50) of the compounds was calculated to be >100,000, >8000 and >80,000 for 
fucoidan, ulvan and their mixture, respectively. Fucoidan showed the most potent antiviral activity at a 
concentration of 0.1 μg/mL, inhibiting by 66% the syncytia formation; ulvan and the mixture at 0.1 μg/mL 
inhibited syncytia by 51.54% and 58.67%, respectively (Table 1). 
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Although fucoidan showed a better antiviral activity than ulvan, ulvan itself exhibited a good ability 
to inhibit syncytia formation. Similar results were obtained previously with brown algae SP and green 
algae ulvans against enveloped viruses [3,4,10,34,35]. There is just one report that correlates the 
chemical structure of ulvan with its antiviral activity [35]; the authors attributed the antiviral activity of 
U. lactuca ulvan to its high molecular weight (MW) based on the work of Lee et al. [36], who reported 
that SP with higher MW have better antiviral activities. In our previous report [3] we assessed the 
antiviral activity of C. okamuranus fucoidan, which has a significant content of glucuronic acid (23%) 
and low levels of sulphatation (9.6%). U. clathrata ulvan studied in present work has a higher level of 
sulphatation (11%) and a lower level of glucuronic acid (13.9%). More reports are needed in order to 
correlate the chemical structure of ulvans with their antiviral effect. 
We apparently observed a decrease of the antiviral activity for the mixture in comparison with 
fucoidan alone, probably by a kind of antagonism. Our results agree with a previous report [3] where  
we determined the antiviral activity and mechanism of action of C. okamuranus fucoidan against  
NDV, demonstrating the powerful antiviral activity of fucoidan. We expected a greater effect from the 
mixture. Combination chemotherapy with synergistically active antiviral agents that have different 
targets from each other for viral replication may offer several advantages over single agent therapy, such 
as greater potency, superior clinical efficacy, reduction of toxicity and side effects due to the reduction 
of the drug dosage needed, suppression of the emergency of drug—resistant viruses, and greater cost 
effectiveness [37]. Hayashi et al. [37] evaluated the effect of the Undaria pinnatifida fucoidan and the 
FDA-approved drug oseltamivir against influenza H1N1 virus; they observed a synergistic effect of the 
compounds combination due to different targets of their tested compounds on the H1N1 replication cycle 
and determined this synergistic effect by an isolobologram. The conjugates of κ-carrageenans and AZT 
(3′-azido-3′-deoxythymidine) exert synergistic effects on the reduction of the infection of the human 
immunodeficiency virus (HIV) [38]. In contrast, Takebe et al. [39] isolated lectins from red and  
blue-green algae and concluded that the combination of the algae-derived proteins with IFN-α did not 
exert a synergistic or additive effect, leading us to conclude that sulphated polysaccharides have special 
features that could explain their potent antiviral effect. Since there is nowadays no FDA approved 
antiviral drug for NDV, and therefore no possibility to mix our biological metabolite with a commercial 
drug, we determined the antiviral effect of the mixture of two polysaccharides isolated from two different 
algae; we expected a synergism or an additive effect with the mixture; instead of this, the mixture showed 
a decrease in the antiviral activity. We determined the combination effect of the mixture with the median 
effect method described by Chou and Talay [40,41] (Figure 4). Figure 4a depicts the dose-effect 
relationship of the compounds: for a synergistic effect we could expect a sigmoidal plot, but we observed 
a linear plot. The combination index values (CI) (Figure 4b) determined at different effective doses by 
the median effect method, showed that the mixture have a strongest antagonism, CI > I indicates 
antagonism; we corroborated these results with the polygonogram (Figure 4c) where we can see a very 
thick dash line characteristic of the antagonist effect. We suggest that this antagonism is due to 
simultaneous action of both SP on the same target. The median effect method has been used in many 
reports to assess the combo effect of antiviral drugs [42–44]. 
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Figure 4. Dose-effect relationships of fucoidan and ulvan, alone or in combination.  
(a) A dose-effect curve based on data obtained in syncytia reduction assay, the curve depicts 
no sigmoidal (synergism) or plateau effect (summation) shapes indicating an antagonism 
relationship between the SP; (b) Combination Index (CI) values of the mixture of SP at 
different Effective Doses (ED) based on syncytia reduction assay and calculated by the 
median-effect method of Chou and Talalay. CI values > 1 indicates an antagonism effect;  
(c) A polygonogram plot indicating a very strong antagonism (very thick dash line) between 
the SP. 
2.4. Virucidal Activity of Ulvan 
Mendes et al. [10] demonstrated that algae extracts from Ulva fasciata have the possibility to 
inactivate virions. To analyse the possibility that U. clathrata ulvan acts directly on the virus particle, 
leading to infectivity inactivation, a virucidal assay against NDV virions was conducted. Ulvan did not 
exert virucidal effect against NDV virions at the tested concentrations, indicating that the inhibitory 
effect detected by the syncytia reduction assay was actually due to an interference with some step of the 
NDV replication cycle (Table 2). The lack of virucidal activity is in agreement with previous studies 
with the C. okamuranus fucoidan [3,33] and other pure algae SP that cannot induce significant virions 
inactivation [45–47]. 
Table 2. Virucidal assay based in the presence or absence of the cytopathic effect of NDV. 
  Time 
Viral Titer 
1 × 104 TCID50 1 × 10
5 TCID50 
 CC  ― ― 
 CV  +++ +++ 
Ulvan concentrations 
10 μg/mL 0 h +++ +++ 
10 μg/mL 3 h +++ +++ 
10 μg/mL 6 h +++ +++ 
100 μg/mL 0 h +++ +++ 
100 μg/mL 3 h  +++ +++ 
100 μg/mL 6 h +++ +++ 
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2.5. Ability of the SP to Block NDV-Induced Cell-Cell Fusion 
To determine whether the compound inhibits the cell-cell spread of NDV, we performed cell fusion 
inhibition assays as described in the experimental section. The NDV envelope contains two proteins 
related to entry: the attachment protein HN and the fusion protein F. After one replication cycle, both 
glycoproteins are displayed in the cell envelope. Fusion of an infected cell with a non-infected occurs 
due to the recognition of sialic acid by HN and a conformational change of F protein, driving to syncytia 
formation, the characteristic cytopathic effect of NDV. Avirulent strains of NDV are characterized by 
their inability to form syncytia because the F0 protein cannot be cleaved in F1/F2. However, after trypsin 
digestion, syncytia formation was observed. Our results show that the SP and their mixture inhibited 
syncytia formation only if they were added before F protein cleavage (before trypsin digestion;  
Figure 5B). Before F protein cleavage, the mixture inhibited syncytia formation by 67% and reduced the 
syncytia size, compared with the findings in untreated viral-infected control cells, while fucoidan and 
ulvan inhibited syncytia formation by 47% and 59% respectively; therefore ulvan and the mixture 
apparently have a better anti-NDV cell-cell fusion spread than fucoidan alone. However, after F protein 
cleavage via trypsin digestion, the SP and their mixture lost the ability to inhibit syncytia formation 
(Figure 5A). This suggests that ulvan inhibits viral fusion by interacting with the intact F0 protein  
but not with the mature protein, as previously found with fucoidan [3], and that ulvan has the same 
mechanism of action as fucoidan. 
 
Figure 5. Inhibition of an avirulent NDV (La Sota) strain-mediated cell fusion. (A) Fusion 
inhibition assay with SP and their mixture treatment before, before cleavage [BC] and after 
F protein cleavage, after cleavage [AC]. Data are expressed as the percent of the number of 
syncytia compared with the findings in virus-infected control cells. VC, viral control; F, 
fucoidan; U, ulvan; M, mixture. The data shown are the mean ± SD of triplicate experiments. 
The asterisks indicate a significant difference between the treatment and viral control  
(* p < 0.05 and ** p < 0.001); (B) Vero cells infected with NDV and treated by trypsin 
digestion: (a) Uninfected control cells (100×); (b) Vero cells infected with NDV and treated 
with trypsin (100×); (c) Infected Vero cells were treated with 0.1 μg/mL of the SP and their 
mixture before F protein cleavage, at which point syncytia formation could be inhibited if 
SP were added (100×); (d) Infected Vero cells were treated with SP and their mixture after 
F protein cleavage, and the SP could not inhibit syncytia formation in this condition (100×). 
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Our results agree with other reports about algae SP being able to exert the ability to inhibit the  
cell-cell fusion [48]. Nyberg et al. [49] demonstrated that the yeast-derived SP PI-88 could inhibit the 
cell-cell spread fusion and consequent syncytia formation by HSV in GMK AH1 cells. Cagno et al. [50] 
reported the anti-cell-cell spread fusion of SP derived from Escherichia coli of RSV; they observed a 
considerable reduction of syncytia inHep-2 and A549 cells. Thus SP from different sources could be 
powerful inhibitors of viral cell-cell fusion. 
3. Experimental Section 
3.1. Antiviral Agents 
3.1.1. Fucoidan from Cladosiphon okamuranus 
Fucoidan was purchased as a dried powder from Kadoya & Co., Kobe, Japan (lot A03012), extracted 
(as described by Tako et al. 2000 [51] from cultured kelp Cladosiphon okamuranus harvested off the 
coast of Okinawa Island, Japan. The polysaccharide preparation was certified to contain 90.4% fucoidan 
(anthrone-sulfuric acid method) and exhibit a mean molecular weight of 92.1 kDa (size exclusion HPLC 
method). The fucose and sulphate content of fucoidan were of 38.6% and 15.9%, respectively, with ash 
comprising 9.6% of the content and other sugars comprising 23% (glucuronic acid and traces of xylose). 
Dried samples of fucoidan were suspended in Dulbecco’s modified Eagle’s medium (DMEM) at a 
concentration of 2.5 mg/mL and filtered through a membrane filter (pore size, 0.22 mm). 
3.1.2. Ulva clathrata Culture 
Ulva clathrata biomass was cultivated at Los Mochis, Sinaloa, México, under a patented technology 
developed for high yield and low cost production, from a clonal laboratory stock of an U. clathrata 
known strain [52]. Ulva sample was collected as described in Peña-Rodriguez et al. [15] from the  
pooled production of two shrimp culture ponds (7800 and 8400 m2) after a two month growing period 
(1 March–6 May 2008), with temperatures at 8:00 and 16:00 in ranges of 18–27 and 21–32 °C; initial 
algal biomass density was 11–12 g/m2 and reached 2 kg fresh weight/m2. The Ulva fresh biomass was 
washed in freshwater to remove sediment, and epiphytes, it was then pressed and dried at 50 °C in an 
industrial hot air dryer, and ground in the same industrial plant. The chemical composition of this sample 
was reported by Peña-Rodriguez et al. [15] as the large scale system (LSS) production. 
3.1.3. Extraction of Ulvan 
A sample of dried Ulva clathrata was extracted at CEVA, France according to the procedure 
described by Robic et al. [16]. Dry ground seaweed tissue was soaked and stirred for 3 days at room 
temperature in 78% ethanol and recovered by filtration on a 100-μm sieve. The wet, depigmented cake 
of ground seaweeds was rinsed with deionized water and was extracted and purified by tangential 
ultrafiltration as described by Robic et al. [16]. Dried samples of ulvan were suspended in Dulbecco’s 
modified Eagle’s medium (DMEM) at a concentration of 2.5 mg/mL and filtered through a membrane 
filter (pore size, 0.22 mm). 
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3.1.4. Characterization of Ulva clathrata Powder and Ulvan Extract 
Dry solid content was determined from the loss in weight of samples kept for 24 h at 103 °C in a 
ventilated furnace. Ash content was quantified gravimetrically after 12 h at 550 °C. Sulphate content was 
measured according to Tabatabai [17]. Protein content was estimated using the Kjeldahl nitrogen  
method [53]. Neutral sugar and uronic acid composition was determined after methanolysis in MeOH-HCl 
and HPLC analysis using an Absorbosphere RP18 column (5 μm, 4 mm × 250 mm, Grace, Deerfield, IL, 
USA) according to Quemener et al. [18]. Molecular weight of the ulvan was determined as described by 
Robic et al. [29]: briefly, ulvan was injected on a high-performance size exclusion chromatography 
(HPSEC) system (Agilent 1100 Series HPLC Value System, Santa Clara, CA, USA) constituted of a  
8 × 300 mm Shodex OHpak SB-806M HQ column (Showa Denko KK, Miniato, Japan) and a 6 × 50 mm 
Shodex OHpak SB-G guard column (Showa Denko KK, Miniato, Japan) eluted at 0.7 mL.min-1 with  
50 mM NaNO3 containing 0.02% NaN; on-line molar mass determinations were performed using a 
multi-angle laser light scattering (MALLS) detector (mini-Dawn Wyatt, Santa Barbara, CA, USA) 
operating at three angles: 41°, 90° and 138° and a differential refractometer (ERC 7517A; Erma Inc., 
Tokyo, Japan), and a UV detector at 280 nm (LDC ⁄ Milton Roy SpectroMonitor 3000; LDC S.A., Paris, 
France)). Average molecular weight was calculated using ASTRA 1.4 software (Wyatt, Santa Barbara, 
CA, USA). The FTIR spectra of dried and ground algal material were recorded using a Thermo Scientific 
Nicolet 380 FT-IR spectrometer (Thermo Electron Scientific Instruments LLC, Madison, WI, USA) 
equipped with a Diamond ATR sampling device (Thermo Electron Scientific Instruments LLC, 
Madison, WI, USA), and using ASTM E204 protocols. For NMR analysis, 70 mg of sample were 
dissolved in D2O, then lyophilized, and dissolved again in D2O with 3-(trimethylsilyl)-propionic-2,2,3, 
3-d4 acid, sodium salt as zero reference. The NMR spectra were recorded at 25 °C using a Bruker Avance 
DPX 400 spectrometer (Bruker Mexicana, Mexico city, Mexico) equipped with gradients and a 5 mm 
multinuclear probe at base frequency of 100 MHz for 13C and 400 MHz for 1H. 
3.2. Cell Line and VIRUS 
Green African monkey kidney (Vero) cells were grown in DMEM/FL-12 supplemented with 5% (v/v) 
fetal bovine serum and 1% (v/v) antibiotics. The flasks were maintained in a humidified atmosphere 
with 5% CO2 at 37 °C. The La Sota NDV strain was obtained from FORT DODGE® (Pfizer, New York, 
NY, USA) and tittered by fifty percent tissue culture infectious dose (TCID50) assay, according to their 
CPE effect as described by Reed and Muench [54]. 
3.3. Cytotoxicity Assay 
To evaluate the cytotoxicity of the compounds MTT’s assays were performed. Vero cells were seeded 
in 96-well plates at an initial density of 7 × 103 cells per well. The cells were incubated with increasing 
concentrations of the SP diluted in DMEM, for 48 h at 37 °C and 5% CO2. MTT (3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium bromide; 0.5 mg/mL; 40 μL/well) was added to the cells, which were further 
incubated for 1 h 15 min. MTT was removed, and dimethylsulfoxide (DMSO; 100 μL/well) was added 
to dissolve the formazan crystals. The optical density of the cells was measured at 570 nm (Synergy™ 
HT multi-mode microplatereader; BIOTEK instruments Inc., Winooski, VT, USA). Each experiment 
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was performed in triplicate, and experiments were repeated at least three times. The cytotoxicity was 
expressed as the CC50, which was the concentration of the test substances that inhibited the growth Vero 
cells by 50% compared with the growth of the untreated cells. 
3.4. Virucidal Assay 
The virucidal activity of ulvan against La Sota NDV was assessed using syncytia reduction assays 
with monolayers of Vero cells grown in 24-well plates. The assays where performed by adding the SP 
(0, 10, or 100 μg/mL) to an equal volume to NDV (1 × 104 and 1 × 105 TCID50). After 0, 3 and 6 h, the 
mixtures were added to Vero cells and further incubated 1 h at 37 °C. Thereafter, the mixtures were 
removed and DMEM with no serum and antibiotics was added. Because La Sota NDV is an avirulent 
strain, trypsin (0.001%; GIBCO) was added after 24 h to mediate syncytia formation after proteolytic 
cleavage of F0 protein and incubated for 30 min at 37 °C, afterwards trypsin was removed and DMEM 
was added. Monolayers were fixed with methanol:acetone (3:1) then incubated for 24 h at 37 °C and  
5% CO2 and stained with 1% crystal violet in an incubator, after which syncytia presence or absence 
was evaluated. 
3.5. Antiviral Activity 
The antiviral activity of the SP and their mixture against La Sota NDV was assessed using syncytia 
reduction assays with monolayers of Vero cells grown in 24 well plates. The assays were performed 
treating with the SP (0.001–10 μg/mL) and infecting the cells (1 × 105.5 TCID50 of NDV) at the same 
time for 1 h at 37 °C, allowing the virus to adsorb. The residual inoculum was discarded and the cells 
were washed with PBS, after which DMEM was added to the cells. Thereafter, monolayers were treated 
with trypsin (0.001%; GIBCO) for 30 min at 37 °C to allow F0 protein cleavage. Each concentration 
was investigated using three culture wells per each SP and their mixture concentration per experiment, 
the experiments were repeated at least three times. Monolayers were fixed with methanol:acetone (3:1) 
after incubation for 24 h at 37 °C in a 5% CO2 incubator and stained with 1% crystal violet, and 
subsequently syncytia were counted. By reference to the number of syncytia observed in viral control 
monolayers (untreated cultures), the IC50 was determined from dose-response curves. The median effect 
method [41] was used to determined synergism, antagonism or additive effect in the SP mixture. 
3.6. Fusion Inhibition Assay 
To determine if the SP has the possibility to inhibit cell-cell spread of NDV, Fusion inhibition assays 
were performed according to the method reported by Zhu et al. [55]. Vero cell monolayers in 24-well 
plates were infected with 1 × 105.5 TCID50 of La Sota NDV. After 12 h of infection, the monolayers were 
washed two times with PBS, digested by trypsin (0.001%; GIBCO) in DMEM at room temperature for 
20 min, and then washed two times with PBS, the monolayers where incubated in DMEM without 
serum/antibiotics for 12 h. To detect SP ability to inhibit fusion and further cell-cell viral spread, they 
were added to the medium before or after trypsin digestion. Monolayers were fixed with 3:1 
methanol:acetone and stained with 1% crystal violet. 
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3.7. Statistical Analysis 
Data analysis was performed by PASW 18 software (PASW 18.0 (2009), Chicago, IL, USA). All 
variables were tested in triplicate for each experiment and experiments were repeated at least three times. 
The CC50 values were determined by Probit regression analysis. One- way ANOVA with Dunnet’s post 
hoc test was used for comparisons vs. viral control. Values were expressed as the mean ± standard 
deviation (SD). The results of the comparisons vs. viral control were considered significantly different 
if p < 0.05 or highly significantly different if p < 0.001. 
4. Conclusions 
Characterization by chemical analysis indicates that the structure of the obtained sulphated 
polysaccharide is similar to that of ulvan-rich extracts already reported in the literature. 
The SP and their mixture inhibit NDV in vitro and they did not exhibit significant toxicity at effective 
concentrations. Ulvan exerted no direct inactivating effect on virions in virucidal assay. Based on our 
findings from syncytia reduction and cell-cell fusion inhibition assays, we support the concept that  
ulvan acts at the same stages of the infection as fucoidan. The polygonogram and the median-effect plot 
show that ulvan acts as an antagonist of fucoidan in their mixture at the syncytia reduction assay, 
probably because both act on the same target. 
Our results indicate that ulvan inhibits syncytia formation only if it is added before F protein cleavage 
(before trypsin digestion). This suggests that ulvan inhibits viral fusion by interacting with the intact  
F0 protein but not with the mature F protein. Ulvan alone showed better anti cell-cell spread activity 
than fucoidan, and their mixture apparently exhibited more potent effect. 
Understanding the mechanism of antiviral activity of brown and green algae SPs is important for  
their future development as antiviral drugs for clinical or veterinary use. Nevertheless, it would be very 
useful to search for natural compounds that act on different targets along the viral infection process 
(perhaps other compounds from seaweed) and in a synergy with ulvan or fucoidan, in such a way to 
obtain a more effective combination therapy, which could exhibit a viral suppression and lower 
resistance than a single compound. 
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